|
Volumn 87, Issue 1, 2002, Pages
|
Sustained complete remission following a combination of very low intensity chemotherapy with rituximab in an elderly patient with Burkitt's lymphoma.
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CHOP PROTOCOL;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
ETOPOSIDE;
MONOCLONAL ANTIBODY;
PREDNISONE;
RITUXIMAB;
VINCRISTINE;
ADJUVANT THERAPY;
AGED;
ARTICLE;
BREAST TUMOR;
BURKITT LYMPHOMA;
CASE REPORT;
FEMALE;
HUMAN;
IMMUNOTHERAPY;
METASTASIS;
MULTIMODALITY CANCER THERAPY;
MULTIPLE CANCER;
ORBIT TUMOR;
PAGET NIPPLE DISEASE;
PATHOLOGY;
REMISSION;
SALVAGE THERAPY;
SEGMENTAL MASTECTOMY;
AGED;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BREAST NEOPLASMS;
BURKITT LYMPHOMA;
CARCINOMA, INTRADUCTAL, NONINFILTRATING;
COMBINED MODALITY THERAPY;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
ETOPOSIDE;
FEMALE;
HUMANS;
IMMUNOTHERAPY;
MASTECTOMY, SEGMENTAL;
NEOPLASMS, MULTIPLE PRIMARY;
ORBITAL NEOPLASMS;
PREDNISONE;
RADIOTHERAPY, ADJUVANT;
REMISSION INDUCTION;
SALVAGE THERAPY;
VINCRISTINE;
|
EID: 19244379979
PISSN: 03906078
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (9)
|
References (0)
|